ClinConnect ClinConnect Logo
Search / Trial NCT04003038

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Launched by M.D. ANDERSON CANCER CENTER · Jun 27, 2019

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a special treatment called negative pressure wound therapy (NPWT) to see if it helps heal the abdominal incision in obese women who are having breast reconstruction surgery. Typically, after this type of surgery, doctors use standard bandages to cover the surgical site, but this study is exploring whether using NPWT can lead to better healing. The trial is currently recruiting participants who are female, between the ages of 65 and 74, and have a body mass index (BMI) of 30 or higher.

To be eligible for this trial, women must be undergoing a specific type of breast reconstruction that involves taking tissue from the abdomen. Participants will be asked to provide their consent and will receive either the NPWT treatment or standard care during their recovery. It's important to note that women who are pregnant, unable to consent, or have allergies to certain adhesives cannot participate. This study aims to find out if NPWT can improve healing, which could lead to better outcomes for patients undergoing this important surgery.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing a free abdominal flap, including a superficial inferior epigastric artery (SIEA), deep inferior epigastric artery perforator (DIEP), or muscle-sparing transverse rectus abdominus myocutaneous (MS-TRAM) flap for breast reconstruction.
  • Patients are willing and able to give consent.
  • Body mass index (BMI) greater than or equal to 30.0.
  • Exclusion Criteria:
  • Patients who are unable to provide consent.
  • Patients who are suspected or known to be pregnant.
  • Known allergy to topical adhesives.

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Edward H Chang

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials